Levoemopamil Hydrochloride
Modify Date: 2025-09-18 18:12:51
Levoemopamil Hydrochloride structure
|
Common Name | Levoemopamil Hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 101238-54-4 | Molecular Weight | 370.95900 | |
| Density | N/A | Boiling Point | 485.8ºC at 760 mmHg | |
| Molecular Formula | C23H31ClN2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 201.1ºC | |
Use of Levoemopamil HydrochlorideLevemopamil hydrochloride is a blood-brain barrier penetrable calcium channel blocker and a 5-HT2 antagonist. Levemopamil hydrochloride can be used for temporary occlusion and neurological disease research[1]. |
| Name | (2S)-5-[methyl(2-phenylethyl)amino]-2-phenyl-2-propan-2-ylpentanenitrile,hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Levemopamil hydrochloride is a blood-brain barrier penetrable calcium channel blocker and a 5-HT2 antagonist. Levemopamil hydrochloride can be used for temporary occlusion and neurological disease research[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Levemopamil hydrochloride (30 mg/kg；腹腔注射，1 次) 可调节双侧颈动脉阻尼 (BCCA) 过程，降低大鼠脑低血症引起的空间记忆障碍[1]。 Animal Model: Male Han-Wistar rats with bilateral damping of carotid arteries (BCCA)[1] Dosage: 30 mg/kg Administration: Intraperitoneal injection; 30 mg/kg, once Result: Showed no effect on GABA or ACh content in either BCCA or sham-operated control rats. Significantly increased swimming speed of BCCA rats in swimming test. Prevented the increasing of escape latency to reach the hidden platform. |
| References |
| Boiling Point | 485.8ºC at 760 mmHg |
|---|---|
| Molecular Formula | C23H31ClN2 |
| Molecular Weight | 370.95900 |
| Flash Point | 201.1ºC |
| Exact Mass | 370.21800 |
| PSA | 27.03000 |
| LogP | 5.86068 |
| Vapour Pressure | 1.37E-09mmHg at 25°C |
| InChIKey | OBAQQQOVZUCKMH-BQAIUKQQSA-N |
| SMILES | CC(C)C(C#N)(CCCN(C)CCc1ccccc1)c1ccccc1.Cl |
| (2S)-5-[methyl(phenethyl)amino]-2-phenyl-2-propan-2-ylpentanenitrile hydrochloride |
| Levemopamil hydrochloride |